BioWorld and its companion publication Medical Device Daily (MDD) have been acquired by Thomson Reuters, a leading source of intelligent information for businesses and professionals.
It is expected that joining Thomson Reuters will allow the company to further invest in innovation and to grow its offerings. Thomson Reuters is also the provider of Cortellis. Thomson Reuters Cortellis is a single source of pharmaceutical intelligence with flexible delivery options for quicker, more-informed decision making.
Bringing the BioWorld portfolio into Thomson Reuters will strengthen publications by giving journalists access to all the information Thomson Reuters captures on the industry. The news and industry perspective published by BioWorld and MDD will likewise strengthen the information, analytics and insight Thomson Reuters delivers to its customers.
